IMMUNIC, INC. — Investor Relations & Filings
Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of selective, orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company's mission is to create high-quality, oral treatment options that offer comprehensive therapeutic efficacy with favorable safety and tolerability profiles. Its clinical development programs target conditions with significant unmet medical needs, including multiple sclerosis and celiac disease, aiming to provide patients with convenient and effective solutions to manage debilitating symptoms and improve their quality of life.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors | 2026-05-19 | English | |
| 8-K - IMMUNIC, INC. (0001280776) (Filer) | 2026-05-13 | English | |
| 10-Q - IMMUNIC, INC. (0001280776) (Filer) | 2026-05-13 | English | |
| Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | 2026-05-13 | English | |
| Immunic to Participate in Investor and Medical Conferences in May | 2026-04-30 | English | |
| 8-K - IMMUNIC, INC. (0001280776) (Filer) | 2026-04-28 | English |
Browse filings by year
22 years- 2026 33 filings
- 2025 75 filings
- 2024 73 filings
- 2023 39 filings
- 2022 66 filings
- 2021 48 filings
- 2020 59 filings
- 2019 78 filings
- 2018 52 filings
- 2017 59 filings
- 2016 46 filings
- 2015 46 filings
- 2014 72 filings
- 2013 22 filings
- 2012 4 filings
- 2011 4 filings
- 2010 5 filings
- 2009 3 filings
- 2007 1 filing
- 2006 1 filing
- 2005 2 filings
- 2004 2 filings
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
YD Bio Ltd
Develops blood-based cancer diagnostics and regenerative ce…
|
YDES | US | Professional, scientific and te… |
|
Zealand Pharma
A biotechnology company developing peptide-based medicines …
|
ZEAL | DK | Professional, scientific and te… |
|
Zentek Ltd.
Develops and commercializes advanced graphene nanotechnolog…
|
ZTEK | CA | Professional, scientific and te… |
|
Zentek Ltd.
An IP company developing nanotechnology for healthcare, saf…
|
ZTEK | US | Professional, scientific and te… |
|
Ziccum AB
Licenses ambient drying technology for creating thermostabl…
|
ZICC | SE | Professional, scientific and te… |
|
ZYUS Life Sciences Corporation
Clinical-stage developer of non-opioid cannabinoid therapeu…
|
ZYUS | CA | Professional, scientific and te… |
| イノバセル株式会社 | 504A | JP | Professional, scientific and te… |
IMMUNIC, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/10196/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=10196 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=10196 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=10196 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 10196}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMMUNIC, INC. (id: 10196)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.